Y-Intercept (HK)’s Nuvation Bio NUVB Stock Holding History

Y-Intercept (HK)’s Portfolio NUVB Stock Details NUVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-18,398	Closed	-$60K	–	1179
2022 Q2	$60K	Buy	+18,398	New	+$80.2K	0.01%	744

Other funds holding NUVB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Y-Intercept (HK)'s NUVB Position: Q3 2022 in Review

Y-Intercept (HK) sold out of Nuvation Bio (NUVB) in Q3 2022, closing a stake of 18,398 shares — an estimated $60K sold.

Y-Intercept (HK) first reported a position in NUVB in Q2 2022 and held it in 1 quarter. The position peaked at $60K in Q2 2022. 121 funds tracked by Wall St. Rank hold NUVB as of Q3 2022.

Y-Intercept (HK) reported no remaining Nuvation Bio position as of Q3 2022 after selling out during the quarter.
Y-Intercept (HK) sold 18,398 Nuvation Bio shares in Q3 2022, an estimated $60K.
Y-Intercept (HK) first reported a position in Nuvation Bio in Q2 2022 and held it in 1 quarter.
Y-Intercept (HK)'s Nuvation Bio position peaked at $60K in Q2 2022.
121 funds tracked by Wall St. Rank held Nuvation Bio as of Q3 2022.

Based on Y-Intercept (HK)'s 13F filing for Q3 2022, filed 14 Feb 2023.